Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date

Autor: Raybould AL, Sanoff H

Publikováno v: Journal of Hepatocellular Carcinoma, Vol Volume 7, Pp 133-142 (2020)

Alison L Raybould, Hanna Sanoff Department of Medicine, Division of Hematology-Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USACorrespondence: Alison L Raybould Division of Hematology/Oncology, Physicians Office Build

Externí odkaz: https://doaj.org/article/6624ae42dcba4d8287ca63068827cb5f

Future direction of total neoadjuvant therapy for locally advanced rectal cancer.

Autor: Kagawa Y; Department of Gastroenterological Surgery, Osaka General Medical Center, Osaka, Japan., Smith JJ; Department of Surgery, Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fokas E; Department of Radiotherapy and Oncology, University of Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Frankfurt Cancer Institute, Frankfurt, Germany.; Department of Radiation Oncology, CyberKnife and Radiation Therapy, Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.; German Cancer Consortium (DKTK), Frankfurt, Germany., Watanabe J; Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan., Cercek A; Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Greten FR; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Frankfurt Cancer Institute, Frankfurt, Germany.; German Cancer Consortium (DKTK), Frankfurt, Germany.; Institute for Tumour Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany., Bando H; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan., Shi Q; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Garcia-Aguilar J; Department of Surgery, Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Romesser PB; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Horvat N; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sanoff H; Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Hall W; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Kato T; Department of Surgery, NHO Osaka National Hospital, Osaka, Japan., Rödel C; Department of Radiotherapy and Oncology, University of Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Frankfurt Cancer Institute, Frankfurt, Germany.; German Cancer Consortium (DKTK), Frankfurt, Germany., Dasari A; Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan. tyoshino@east.ncc.go.jp.

Publikováno v: Nature reviews. Gastroenterology & hepatology [Nat Rev Gastroenterol Hepatol] 2024 Jun; Vol. 21 (6), pp. 444-455. Date of Electronic Publication: 2024 Mar 14.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer.

Autor: Alvarez J, Shi Q, Dasari A, Garcia-Aguilar J, Sanoff H, George TJ, Hong TS, Yothers G, Philip PA, Nelson GD, Al Baghdadi T, Alese O, Zambare W, Omer DM, Verheij FS, Buckley J, Williams H, George M, Garcia R, O'Reilly EM, Meyerhardt JA, Shergill A, Horvat N, Romesser PB, Hall WA, Smith JJ

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Apr 27. Date of Electronic Publication: 2024 Apr 27.

Predicting Acute Care Events Among Patients Initiating Chemotherapy: A Practice-Based Validation and Adaptation of the PROACCT Model.

Autor: Stein JN; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Division of Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC., Dunham L; North Carolina Cancer Hospital, Chapel Hill, NC., Wood WA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Division of Hematology, Department of Medicine, University of North Carolina, Chapel Hill, NC., Ray E; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Division of Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC., Sanoff H; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Division of Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC.; North Carolina Cancer Hospital, Chapel Hill, NC., Elston-Lafata J; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Divison of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC.

Publikováno v: JCO oncology practice [JCO Oncol Pract] 2023 Aug; Vol. 19 (8), pp. 577-585. Date of Electronic Publication: 2023 May 22.